Page last updated: 2024-08-23

amikacin and Benign Neoplasms

amikacin has been researched along with Benign Neoplasms in 112 studies

Research

Studies (112)

Timeframe	Studies, this research(%)	All Research%
pre-1990	39 (34.82)	18.7374
1990's	30 (26.79)	18.2507
2000's	23 (20.54)	29.6817
2010's	15 (13.39)	24.3611
2020's	5 (4.46)	2.80

Authors

Authors	Studies
Almeida, MCS; Barreto, FS; Braz-Filho, R; Costa, JGM; da S Souza, LG; de Brito, ES; de Moraes, MO; Lemos, TLG; Ribeiro, PRV; Rodrigues, FFG; Silva, AMS; Silva, VLM	1
Caruso, P; de Lima Moreira, F; de Souza Borges, O; Diegues, MS; E Silva, ILF; Gavazza, BV; Migotto, KC; Pinto, L; Reghini, R; Schmidt, S; Telles, JP	1
Charoenkwan, P; Choeyprasert, W; Fanhchaksai, K; Kamonrattana, R; Natesirinilkul, R; Sathitsamitphong, L	1
Juan-Shum, L; López-Aguilar, JE; Miranda-Novales, MG; Pacheco-Rosas, DO; Peregrino-Bejarano, L	1
Aitken, SL; Gerges, B; Prince, RA; Raad, I; Rolston, KVI; Shelburne, S	1
Huh, HJ; Kang, JM; Kim, YJ; Koo, HH; Lee, JW; Lee, NH; Lee, NY; Sung, KW; Yoo, KH	1
Allegaert, K; Dewandel, I; Laenen, A; Renard, M; Smits, A	1
Chen, Y; Du, Z; Liu, Y; Wang, Y; Yang, Z	1
Cyriac, SL; Dubashi, B; Harish, BH; Jadhav, N; Jaffa, E; Kayal, S; Matta, KK; Pattnaik, J; Pillai, US; Ponraj, M; Prakash, B; Ranjith, K; Singh, J	1
Allegaert, K; De Cock, P; Healy, DP; Kagan, RJ; Liu, X; Renard, M; Sherwin, CMT; Smits, A; Wang, Y; Wead, S	1
Bach, A; Chen, KS; Shoup, A; Winick, NJ	1
Bach, A; Chen, K; Shoup, A; Winick, N	1
Castagnola, E; Dallorso, S; Haupt, R	1
Emiroğlu, M; Köksal, Y; Köse, D	1
Adderson, EE; Apiwattankul, N; Flynn, PM; Hayden, RT	1
Agarwala, S; Bakhshi, S; Gupta, A; Pandey, RM; Swaroop, C	1
Akduman, D; Ankarali, H; Aydemir, H; Celebi, G; Engin, H; Gokmen, A; Keskin, AS; Oztoprak, N; Piskin, N	1
Bratt, GW; Dille, MF; Fausti, SA; Gallun, F; Gordon, JS; Helt, WJ; Konrad-Martin, D; Reavis, KM	1
Landau, Z; Miller, EB; Shichmanter, R; Shtalrid, M	1
Bompolaki, I; Bozionelou, V; Falagas, ME; Kalpadaki, C; Karageorgopoulos, DE; Koutsounaki, E; Mitsikostas, P; Samonis, G; Sgouros, J; Taktikou, V	1
Aparicio, J; Bosch, C; Galan, A; Giner, V; Juan, O; Molins, C; Montalar, J; Segura, A	1
Blot, N; Marie-Cardine, A; Schneider, P; Tron, P; Vannier, JP	1
Afif, C; Boktour, MR; Escalante, C; Hachem, RY; Hanna, HA; Husni, R; Jacobson, K; Kantarjian, H; Kontoyiannis, D; Levett, LM; Raad, II; Rolston, KV; Whimbey, EE	1
Chiu, HH; Hung, KC; Lin, HC; Peng, CT; Tsai, FJ; Tseng, YC; Wang, JH	1
Aksoylar, S; Cetingül, N; Kansoy, S; Kantar, M; Karapinar, D; Kavakli, K	1
Castagnola, E; Caviglia, I; Giona, F; Girmenia, C; Haupt, R; Micozzi, A; Parodi, S; Testi, AM	1
Aguado, JM; Colomer, R; Cortés-Funes, H; López-Martín, A; López-Medrano, F; Lumbreras, C; Rodríguez, FJ; Sánchez-Muñoz, A	1
Bermúdez, A; Besalduch, J; Nocea, G; Pascual, MJ; Rovira, M; Sanz, MA; Sanz-Rodríguez, C	1
Amador, ML; Arcediano, A; Bazares, S; Castellano, D; Ciruelos, E; Cortés-Funes, H; González-Cortijo, L; Hornedo, J; Jimeno, A; Lumbreras, C; Paz-Ares, L; Robles, L	1
Ahmed, IA; Ahmed, N; El-Beshlawy, A; El-Haddad, A; El-Mahallawy, HA; Nassif, S	1
Rosoff, PM; Saini, S	1
Hamidah, A; Jamal, R; Lim, YS; Nordiah, AJ; Zarina, AL; Zulkifli, SZ	1
Laoprasopwattana, K; Laosombat, V; Pruekprasert, P; Wongchanchailert, M	1
Hamidah, A; Jamal, R; Nordiah, AJ; Rizal, AM	1
De Jongh, CA; Finley, RS; Fortner, CL; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Standiford, HC; Wade, JC; Wiernik, PH	1
Klastersky, J	2
Jacquillat, C; Khayat, D; Maral, J	1
Fortner, CL; Newman, KA; Schimpff, SC; Standiford, HC; Wade, JC; Wiernik, PH	1
Klastersky, J; Lagast, H; Meunier, F; Piccart, M; Van Laethem, Y; Weerts, D	1
Hattori, M; Honda, T; Sampi, K	1
de Jongh, CA; Joshi, JH; Newman, KA; Schimpff, SC; Tenney, JH	1
Britten, J; Caplan, E; deJongh, CA; Finley, RS; Fortner, CL; Newman, KA; Schimpff, SC; Wade, JC; Wiernik, PH	1
de Jongh, CA; Moody, MM; Schimpff, SC; Tillman, GL	1
Deshpande, G; Faden, H; Grossi, M	1
Deshpande, GN; Ettinger, LJ; Faden, HS; Freeman, AI; Grossi, M; Surgalla, M	1
Costa, MA; Martins, CA; Nucci, M; Velasco, E	1
Calandra, T; Cometta, A; de Bock, R; Gaya, H; Glauser, MP; Klastersky, J; Langenaeken, J; Paesmans, M; Viscoli, C; Zinner, S	1
Bucaneve, G; Buelli, M; Carotenuto, M; D'Antonio, D; Gentile, G; Liso, V; Martino, P; Menichetti, F; Nosari, AM; Ricci, P	1
Artiges, V; Bouffet, E; Bouhour, D; Brunat Mentigny, M; Charra, C; Couillioud, D; Frappaz, D; Fuhrmann, C	1
Daghistani, D; Horn, M; Rodriguez, Z; Schoenike, S; Toledano, S	1
Blaise, D; Cordonnier, C; Espinouse, D; Herbrecht, R; Leblond, V; Minozzi, C; Sadoun, A; Sauvage, C	1
Bucaneve, G; Calandra, T; Cometta, A; Crokaert, F; de Bock, R; Del Favero, A; Gaya, H; Glauser, MP; Kern, WV; Klastersky, J; Langenaeken, I; Micozzi, A; Padmos, A; Paesmans, M; Viscoli, C; Zinner, SH	1
Deweerdt, C; Maire, P; Pivot-Dumarest, C; Roux, D; Sorensen, P; Troncy, J	1
Charnas, R; Lüthi, AR; Ruch, W	1
Böhme, C; Hess, U; Rey, K; Senn, HJ	1
Krcmery, V; Krupova, Y; Mateicka, F; Novotny, J; Sabo, A	1
Colomer, R; Cortés-Funes, H; García-Carbonero, R; Gómez, C; Hidalgo, M; Hornedo, J; Lumbreras, C; Perea, S; Ruiz, A; Trigo, JM	1
Castagnola, E; Dini, G; Giacchino, R; Lanino, E; Viscoli, C	1
Cometta, A; De Bock, R; Gaya, H; Kern, WV; Langenaeken, J; Paesmans, M	1
Başkan, S; Ozyilkan, O; Yalçintaş, U	1
Chastagner, P; Eyer, D; Lozniewski, A; Plesiat, P; Plouvier, E; Sommelet, D	1
Armada, AA; Casimir, L; De Martino, MG; Debbag, R; Fernandez, C; Paganini, HR; Rodriguez-Brieshcke, MT; Sarkis, CM; Zubizarreta, PA	1
Arasu, A; Ariffin, H; Ariffin, WA; Chan, LL; Lin, HP; Mahfuzah, M	1
Abi-Said, D; Bivins, C; Hachem, R; Hanna, H; Huaringa, A; Raad, I; Sukumaran, A; Thornby, J; Walsh, G; Whimbey, E	1
Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P	1
Agaoglu, L; Agirbasli, H; Anak, S; Bilgen, H; Biner, B; Can, M; Devecioglu, O; Eryilmaz, E; Gedikoglu, G; Goksan, B; Karakas, Z; Unuvar, A; Yalman, N	1
Baka, M; Gombakis, N; Kafetzis, DA; Koliouskas, DE; Kosmidou, H; Malaka-Zafiriou, E; Maltezou, HC	1
Brennscheidt, U; Cornely, O; Figuera, A; Glauser, MP; Grigg, A; Keyserling, C; Tack, K; Trostmann, U; Welling, L	1
Moody, MR; Purvis, DS; Schimpff, SC; Wiernik, PH; Young, VM	1
Schimpff, SC	1
Fortner, CL; Hahn, DM; Schimpff, SC; Standiford, HC; Wiernik, PH; Young, VM	1
Hopefl, AW	1
Bender, JF; Fortner, CL; Hahn, DM; Love, LJ; Schimpff, SC; Standiford, HC; Wiernik, PH; Young, VM	1
Gaya, H	1
Bodey, GP; Feld, R; Rodriguez, V; Valdivieso, M	2
Bodey, GP; Keating, MJ; Rodriguez, V; Valdivieso, M	1
Cleary, T; Frankel, LS; Kohl, S; Kramer, WG; Pickering, LK	1
Cleary, TG; Culbert, S; Frankel, LS; Kohl, S; Kramer, WG; Pickering, LK	1
Bodey, GP; Keating, MJ; Samaan, NA; Sethi, MR	1
Kowarski, A; Lietman, PS; Vogelstein, B	1
Debusscher, L; Klastersky, J; Prevost, JM; Weerts-Ruhl, D	1
Ajarim, DS; al Mohareb, F; al Momen, AK; Harakati, MS; Santhosh-Kumar, CR; Zeitany, RG	1
Artal, A; Berrocal, A; Chacón, I; Espinosa, E; Feliu, J; García de Paredes, ML; González Barón, M; Montero, JM; Ordóñez, A; Zamora, P	1
Cimino, G; Gentile, G; Girmenia, C; Martino, P; Micozzi, A; Raccah, R; Sgadari, C	1
Fuchsberger, P; Horníková, M; Koza, I; Krcméry, V; Kusenda, Z; Mardiak, J; Spánik, S; Sufliarsky, J; Svec, J; Trupl, J	1
Anaissie, EJ; Berkey, P; Bodey, GP; Cabanillas, FF; Elting, L; Holmes, FA; Joshi, JH; Keating, MJ; Khardori, NM; Rolston, KV	1
Anak, S; Devecioğlu, O; Gedikoğlu, G; Ovali, F; Zülfikar, B	1
Jeschko, M; Pedrazzini, A; Schafroth, U; Schmid, L; Senn, H; Thürlimann, B; Wilder-Smith, C	1
Calandra, T; Gaya, H; Glauser, M; Klastersky, J; Meunier, F; Viscoli, C; Zinner, SH	1
Davis, RL; Lehmann, D; Neidhart, J; Stidley, CA	1
Citerio, P	1
Aoun, M; Bron, D; Meunier, F; Van der Auwera, P	1
Bodey, GP; Ho, DH; Rolston, K	1
Smolianskaia, AZ	1
Calandra, T; Gaya, H; Glauser, MP; Klastersky, J; Meunier, F; Zinner, SH	1
Baker, DK; Blankenship, KR; Feldman, S; Gigliotti, F; Hughes, WT; Meyer, WH; Roberson, PK; Santana, VM; Shenep, JL; Sixbey, JW	1
Artino, RM; Dotti, G; Giacchino, M; Grazia, G; Madon, E; Mattirolo, F; Miniero, R; Vivalda, M	1
Ameglio, F; Casali, A; Gallo Curcio, C; Gionfra, T; Paoletti, G; Tonachella, R	1
Hattori, M; Kaneko, Y; Kumai, R; Maseki, N; Sakurai, M; Sampi, K	1
De Jongh, CA; Drusano, GL; Finley, RS; Joshi, JH; Moody, MR; Newman, KA; Salvatore, PC; Schimpff, SC; Tenney, JH; Thompson, BW	1
Benedetti, M; Canobbio, L; Fassio, T; Figoli, F; Galligioni, E; Gasparini, G; Talamini, R; Toffoli, G; Tumolo, S	1
Klastersky, J; Lagast, H; Meunier, F; Snoeck, R; Woussen, F	1
Zinner, SH	1
Hattori, M; Kaneko, Y; Kumai, R; Sakurai, M; Sampi, K	1
Blowers, EC; Natarajan, A; Rana, S	1

Reviews

5 review(s) available for amikacin and Benign Neoplasms

Article	Year
Meta-analysis: combination of meropenem vs ceftazidime and amikacin for empirical treatment of cancer patients with febrile neutropenia. Medicine, 2021, Feb-26, Volume: 100, Issue:8 Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Febrile Neutropenia; Humans; Meropenem; Neoplasms	2021
Infections Caused by Rapidly Growing Mycobacteria spp in Children and Adolescents With Cancer. Journal of the Pediatric Infectious Diseases Society, 2015, Volume: 4, Issue:2 Topics: Adolescent; Amikacin; Anti-Infective Agents; Catheter-Related Infections; Child; Child, Preschool; Clarithromycin; Debridement; Female; Humans; Immunocompromised Host; Infant; Lung Diseases; Male; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Neoplasms; Retrospective Studies	2015
Febrile neutropenia. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1993, Volume: 1, Issue:5 Topics: Amikacin; Amphotericin B; Bacteremia; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Fever of Unknown Origin; Humans; Mycoses; Neoplasms; Neutropenia; Vancomycin; Virus Diseases	1993
Empiric therapy of febrile granulocytopenic patients. American journal of hospital pharmacy, 1979, Volume: 36, Issue:2 Topics: Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Blood Transfusion; Cephalosporins; Drug Therapy, Combination; Gentamicins; Granulocytes; Humans; Klebsiella Infections; Neoplasms; Penicillins; Pseudomonas Infections; Staphylococcal Infections; Tobramycin	1979
Small molecule adenosine 5'-monophosphate activated protein kinase (AMPK) modulators and human diseases. Journal of medicinal chemistry, 2015, Jan-08, Volume: 58, Issue:1 Topics: Adenine Nucleotides; Allosteric Regulation; AMP-Activated Protein Kinases; Humans; Intracellular Signaling Peptides and Proteins; Metabolic Diseases; Molecular Structure; Neoplasms; Protein Structure, Tertiary; Small Molecule Libraries	2015

Trials

62 trial(s) available for amikacin and Benign Neoplasms

Article	Year
A Randomized, Open-Labeled, Prospective Controlled Study to Assess the Efficacy of Frontline Empirical Intravenous Piperacillin/Tazobactam Monotherapy in Comparison with Ceftazidime Plus Amikacin for Febrile Neutropenia in Pediatric Oncology Patients. Asian Pacific journal of cancer prevention : APJCP, 2019, 09-01, Volume: 20, Issue:9 Topics: Administration, Intravenous; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Febrile Neutropenia; Female; Follow-Up Studies; Humans; Male; Neoplasms; Piperacillin; Prospective Studies; Retrospective Studies; Tazobactam; Treatment Outcome	2019
Piperacillin/tazobactam plus amikacin vs. piperacilin/tazobactam: treatment for children with febrile neutropenia Revista medica del Instituto Mexicano del Seguro Social, 2019, Jul-31, Volume: 57, Issue:2 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Child; Child, Preschool; Febrile Neutropenia; Female; Hematologic Neoplasms; Humans; Infant; Intention to Treat Analysis; Logistic Models; Male; Neoplasms; Piperacillin, Tazobactam Drug Combination	2019
Cefepime vs. cefoperazone/sulbactam in combination with amikacin as empirical antibiotic therapy in febrile neutropenia. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2018, Volume: 26, Issue:11 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents; Cefepime; Cefoperazone; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Sulbactam; Survival Analysis; Withholding Treatment; Young Adult	2018
Randomized controlled trial comparing oral amoxicillin-clavulanate and ofloxacin with intravenous ceftriaxone and amikacin as outpatient therapy in pediatric low-risk febrile neutropenia. Journal of pediatric hematology/oncology, 2009, Volume: 31, Issue:9 Topics: Administration, Oral; Adolescent; Ambulatory Care; Amikacin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Ceftriaxone; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Injections, Intravenous; Male; Neoplasms; Neutropenia; Ofloxacin; Treatment Outcome	2009
Piperacillin-tazobactam versus carbapenem therapy with and without amikacin as empirical treatment of febrile neutropenia in cancer patients: results of an open randomized trial at a university hospital. Japanese journal of clinical oncology, 2010, Volume: 40, Issue:8 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carbapenems; Drug Eruptions; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multivariate Analysis; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies; Survival Rate; Young Adult	2010
Cefepime monotherapy as an empirical initial treatment of patients with febrile neutropenia. Medical oncology (Northwood, London, England), 2002, Volume: 19, Issue:3 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Multicenter Studies as Topic; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin	2002
Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. Cancer, 2003, Sep-01, Volume: 98, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Catheterization, Central Venous; Cefepime; Cephalosporins; Female; Fever; Hospitalization; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Practice Guidelines as Topic; Prospective Studies; Risk Factors; Vancomycin	2003
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empirical therapy for neutropenic fever in children with malignancy. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2003, Volume: 36, Issue:4 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftazidime; Chemical and Drug Induced Liver Injury; Child; Child, Preschool; Diarrhea; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Cocci; Hospitals, University; Humans; Infant; Male; Meropenem; Neoplasms; Neutropenia; Taiwan; Thienamycins; Treatment Outcome	2003
Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children. Pediatric hematology and oncology, 2004, Volume: 21, Issue:2 Topics: Amikacin; Anti-Bacterial Agents; Drug Therapy, Combination; Fever; Fungi; Gram-Negative Bacteria; Gram-Positive Bacteria; Hematologic Neoplasms; Humans; Infections; Meropenem; Neoplasms; Netilmicin; Neutropenia; Penicillanic Acid; Piperacillin; Tazobactam; Thienamycins	2004
Imipenem/cilastatin versus piperacillin/tazobactam plus amikacin for empirical therapy in febrile neutropenic patients: results of the COSTINE study. Current medical research and opinion, 2005, Volume: 21, Issue:5 Topics: Adult; Amikacin; Anti-Bacterial Agents; Cilastatin; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Hematopoietic Stem Cell Transplantation; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prospective Studies; Protease Inhibitors; Spain; Tazobactam; Treatment Outcome	2005
Randomized study of cefepime versus ceftazidime plus amikacin in patients with solid tumors treated with high dose chemotherapy (HDC) and peripheral blood stem cell support (PBSCS) with febrile neutropenia. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2006, Volume: 8, Issue:12 Topics: Adult; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Cefepime; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Stem Cell Transplantation; Treatment Outcome	2006
Early hospital discharge versus continued hospitalization in febrile pediatric cancer patients with prolonged neutropenia: A randomized, prospective study. Pediatric blood & cancer, 2007, Volume: 49, Issue:6 Topics: Ambulatory Care; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Costs and Cost Analysis; Female; Humans; Injections, Intravenous; Length of Stay; Male; Neoplasms; Neutropenia; Patient Discharge; Prospective Studies; Risk Factors; Sepsis; Time Factors	2007
Cefepime plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients. Singapore medical journal, 2007, Volume: 48, Issue:7 Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Remission Induction	2007
Clinical outcome of febrile neutropenia in children with cancer using ceftazidime and aminoglycosides. Pediatric hematology and oncology, 2007, Volume: 24, Issue:8 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Child; Child, Preschool; Disease-Free Survival; Female; Gentamicins; Guidelines as Topic; Humans; Imipenem; Infant; Male; Neoplasms; Neutropenia; Prospective Studies; Survival Rate	2007
Piperacillin-tazobactam plus amikacin as an initial empirical therapy of febrile neutropenia in paediatric cancer patients. Singapore medical journal, 2008, Volume: 49, Issue:1 Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2008
Empiric antibiotic therapy for suspected infection in granulocytopenic cancer patients: a comparison between the combination of moxalactam plus amikacin and ticarcillin plus amikacin. The American journal of medicine, 1982, Volume: 73, Issue:1 Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cephalosporins; Cephamycins; Child; Double-Blind Method; Drug Evaluation; Drug Synergism; Drug Therapy, Combination; Female; Humans; Kanamycin; Male; Middle Aged; Moxalactam; Neoplasms; Penicillins; Prospective Studies; Random Allocation; Ticarcillin	1982
[Role of azlocillin in the treatment of immunocompromised patients. Results of the EORTC (European Organization for Research on the Treatment of Cancer) study)]. Presse medicale (Paris, France : 1983), 1984, Mar-29, Volume: 13, Issue:13 Topics: Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Cefotaxime; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Neoplasms; Penicillins; Ticarcillin	1984
Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1983, Volume: 1, Issue:10 Topics: Agranulocytosis; Amikacin; Bacterial Infections; Carbenicillin; Cefazolin; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Humans; Kanamycin; Kidney Diseases; Neoplasms; Neutropenia	1983
Piperacillin or ticarcillin plus amikacin. A double-blind prospective comparison of empiric antibiotic therapy for febrile granulocytopenic cancer patients. The American journal of medicine, 1981, Volume: 71, Issue:6 Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Leukemia; Male; Middle Aged; Neoplasms; Penicillins; Piperacillin; Prospective Studies; Random Allocation; Ticarcillin	1981
Single-drug versus combination empirical therapy for gram-negative bacillary infections in febrile cancer patients with and without granulocytopenia. Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:6 Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Cefoperazone; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Pseudomonas Infections; Sepsis; Staphylococcal Infections	1984
Comparison of standard versus pharmacokinetically adjusted amikacin dosing in granulocytopenic cancer patients. Antimicrobial agents and chemotherapy, 1982, Volume: 22, Issue:2 Topics: Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Fever; Hearing Loss; Humans; Kanamycin; Kidney; Kinetics; Moxalactam; Neoplasms; Piperacillin; Ticarcillin	1982
Randomized trial comparing oral ciprofloxacin plus penicillin V with amikacin plus carbenicillin or ceftazidime for empirical treatment of febrile neutropenic cancer patients. American journal of clinical oncology, 1995, Volume: 18, Issue:5 Topics: Administration, Oral; Adult; Amikacin; Carbenicillin; Ceftazidime; Ciprofloxacin; Costs and Cost Analysis; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillin V; Prospective Studies	1995
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment Antimicrobial agents and chemotherapy, 1995, Volume: 39, Issue:2 Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Middle Aged; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies	1995
Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:9 Topics: Adolescent; Adult; Aged; Amikacin; Amphotericin B; Bacteremia; Ceftazidime; Drug Therapy, Combination; Female; Fever; Gram-Positive Bacterial Infections; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Teicoplanin; Vancomycin	1994
Once daily antibiotic regimen in paediatric oncology. Archives of disease in childhood, 1994, Volume: 70, Issue:6 Topics: Adolescent; Adult; Amikacin; Bacterial Infections; Ceftriaxone; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Feasibility Studies; Humans; Infant; Neoplasms; Teicoplanin; Vancomycin	1994
Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. The International Antimicrobial Therapy Cooperative Group of the Eu Annals of internal medicine, 1993, 10-01, Volume: 119, Issue:7 Pt 1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Ceftriaxone; Child; Child, Preschool; Drug Administration Schedule; Drug Therapy, Combination; Ear Diseases; Female; Humans; Infant, Newborn; Infections; Kidney Diseases; Male; Middle Aged; Neoplasms; Prospective Studies; Treatment Outcome	1993
Prevention of indwelling central venous catheter sepsis. Medical and pediatric oncology, 1996, Volume: 26, Issue:6 Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Candidiasis; Catheterization, Central Venous; Catheters, Indwelling; Child; Child, Preschool; Double-Blind Method; Drug Therapy, Combination; Female; Heparin; Humans; Incidence; Infant; Infection Control; Inservice Training; Male; Medical Staff, Hospital; Neoplasms; Nursing Staff, Hospital; Prospective Studies; Retrospective Studies; Sodium Chloride; Staphylococcal Infections; Vancomycin	1996
Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients. Journal of chemotherapy (Florence, Italy), 1995, Volume: 7 Suppl 2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Anti-Bacterial Agents; Bone Marrow Transplantation; Ceftriaxone; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever; Gentamicins; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Superinfection	1995
Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:5 Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Fever; Humans; Infant; Meropenem; Middle Aged; Neoplasms; Prospective Studies; Thienamycins	1996
Once daily ceftriaxone plus amikacin vs. three times daily ceftazidime plus amikacin for treatment of febrile neutropenic children with cancer. Writing Committee for the International Collaboration on Antimicrobial Treatment of Febrile Neutropenia in Chil The Pediatric infectious disease journal, 1997, Volume: 16, Issue:4 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Fever; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Infant; Leukemia; Lymphoma; Male; Microbial Sensitivity Tests; Neoplasms; Neutropenia	1997
Monotherapy with piperacillin/tazobactam versus combination therapy with ceftazidime plus amikacin as an empiric therapy for fever in neutropenic cancer patients. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1998, Volume: 6, Issue:4 Topics: Adolescent; Adult; Aged; Amikacin; Analysis of Variance; Anti-Bacterial Agents; Ceftazidime; Chi-Square Distribution; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Prognosis; Prospective Studies; Tazobactam; Treatment Failure; Treatment Outcome	1998
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial. Cancer, 1999, Jan-01, Volume: 85, Issue:1 Topics: Administration, Oral; Adult; Aged; Ambulatory Care; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Ceftazidime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hospitalization; Humans; Injections, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Prospective Studies; Treatment Outcome	1999
Oral versus intravenous empirical antimicrobial therapy for fever in patients with granulocytopenia who are receiving cancer chemotherapy. International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Can The New England journal of medicine, 1999, Jul-29, Volume: 341, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Amoxicillin; Antineoplastic Agents; Bacteremia; Ceftriaxone; Child; Child, Preschool; Ciprofloxacin; Clavulanic Acid; Drug Therapy, Combination; Female; Fever; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Prospective Studies; Survival Rate	1999
Imipenem-cilastatin versus sulbactam-cefoperazone plus amikacin in the initial treatment of febrile neutropenic cancer patients. The Korean journal of internal medicine, 1999, Volume: 14, Issue:2 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amikacin; Bacteremia; Cefoperazone; Cilastatin; Drug Therapy, Combination; Female; Fever; Humans; Imipenem; Male; Middle Aged; Neoplasms; Neutropenia; Prospective Studies; Sulbactam	1999
Oral administration of cefixime to lower risk febrile neutropenic children with cancer. Cancer, 2000, Jun-15, Volume: 88, Issue:12 Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors	2000
Single-daily ceftriaxone plus amikacin versus thrice-daily ceftazidime plus amikacin as empirical treatment of febrile neutropenia in children with cancer. Journal of paediatrics and child health, 2001, Volume: 37, Issue:1 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Ceftriaxone; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Multivariate Analysis; Neoplasms; Neutropenia; Prospective Studies; Statistics, Nonparametric	2001
Treatment of nosocomial postoperative pneumonia in cancer patients: a prospective randomized study. Annals of surgical oncology, 2001, Volume: 8, Issue:2 Topics: Aged; Amikacin; Aztreonam; Chi-Square Distribution; Clindamycin; Cross Infection; Drug Therapy, Combination; Humans; Middle Aged; Neoplasms; Opportunistic Infections; Penicillanic Acid; Piperacillin; Pneumonia, Bacterial; Postoperative Complications; Prognosis; Prospective Studies; Tazobactam	2001
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia. Cancer, 2001, Apr-15, Volume: 91, Issue:8 Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Fever; Fever of Unknown Origin; Humans; Infant; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors; Treatment Outcome	2001
Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey. Journal of chemotherapy (Florence, Italy), 2001, Volume: 13, Issue:3 Topics: Adolescent; Adult; Amikacin; Cefepime; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Meropenem; Neoplasms; Netilmicin; Neutropenia; Prospective Studies; Thienamycins; Turkey	2001
Comparison of isepamicin with amikacin for the empirical treatment of febrile neutropenic children with malignancies. International journal of antimicrobial agents, 2001, Volume: 18, Issue:4 Topics: Amikacin; Anti-Bacterial Agents; Bacterial Infections; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Fever; Gentamicins; Humans; Male; Neoplasms; Neutropenia; Random Allocation	2001
Clinafloxacin monotherapy (CI-960) versus ceftazidime plus amikacin for empirical treatment of febrile neutropenic cancer patients. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2002, Volume: 8, Issue:1 Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Bacterial Infections; Ceftazidime; Cephalosporins; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Fever; Fluoroquinolones; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Teicoplanin; Treatment Outcome; Vancomycin	2002
Therapy of infection in patients with granulocytopenia. The Medical clinics of North America, 1977, Volume: 61, Issue:5 Topics: Agranulocytosis; Amikacin; Anti-Bacterial Agents; Blood Transfusion; Carbenicillin; Cephalothin; Clinical Trials as Topic; Drug Therapy, Combination; Gentamicins; Granulocytes; Humans; Infections; Kidney; Leukocyte Count; Mycoses; Neoplasms; Pseudomonas Infections; Ticarcillin; Tobramycin	1977
Randomized trial of empiric antibiotic therapy with ticarcillin in combination with gentamicin, amikacin or netilmicin in febrile patients with granulocytopenia and cancer. The American journal of medicine, 1979, Volume: 66, Issue:4 Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Gentamicins; Humans; Infections; Kanamycin; Male; Middle Aged; Neoplasms; Penicillin Resistance; Penicillins; Sepsis; Ticarcillin	1979
Empirical therapy in febrile granulocytopenic patients. European journal of cancer, 1979, Volume: 15 Suppl Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Blood Transfusion; Carbenicillin; Cephalothin; Clinical Trials as Topic; Drug Therapy, Combination; Female; Fever; Gentamicins; Granulocytes; Humans; Male; Middle Aged; Neoplasms; Transplantation, Homologous	1979
Comparison of amikacin and tobramycin in the treatment of infection in patients with cancer. The Journal of infectious diseases, 1977, Volume: 135, Issue:1 Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Escherichia coli; Escherichia coli Infections; Female; Humans; Kanamycin; Klebsiella Infections; Klebsiella pneumoniae; Male; Middle Aged; Neoplasms; Pneumonia; Pseudomonas aeruginosa; Pseudomonas Infections; Sepsis; Tobramycin; Urinary Tract Infections	1977
A randomized comparative trial of three aminoglycosides--comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies. Medicine, 1979, Volume: 58, Issue:2 Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Carbenicillin; Drug Therapy, Combination; Female; Gentamicins; Humans; Infusions, Parenteral; Kanamycin; Kidney; Male; Middle Aged; Neoplasms; Neutropenia; Uremia	1979
Comparison of two antibiotic regimens (piperacillin plus amikacin versus ceftazidime plus amikacin) as empiric therapy for febrile neutropenic patients with cancer. Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Piperacillin; Vancomycin	1992
A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients. Archives of internal medicine, 1992, Volume: 152, Issue:2 Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Fever; Humans; Imipenem; Middle Aged; Neoplasms; Neutropenia; Prognosis; Superinfection	1992
The efficacy of mezlocillin-amikacin combination in febrile neutropenic children with oncologic disease. Journal of chemotherapy (Florence, Italy), 1991, Volume: 3, Issue:4 Topics: Adolescent; Amikacin; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Haemophilus Infections; Humans; Infant; Male; Mezlocillin; Neisseriaceae Infections; Neoplasms; Neutropenia; Staphylococcal Infections; Streptococcal Infections	1991
Ceftriaxone and amikacin versus ceftazidime and amikacin in febrile granulocytopenia. Chemotherapy, 1991, Volume: 37, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Ceftriaxone; Drug Therapy, Combination; Female; Fever; Humans; Leukemia; Male; Middle Aged; Neoplasms	1991
Prospective randomized evaluation of ciprofloxacin versus piperacillin plus amikacin for empiric antibiotic therapy of febrile granulocytopenic cancer patients with lymphomas and solid tumors. The European Organization for Research on Treatment of Cancer Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:5 Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ciprofloxacin; Drug Therapy, Combination; Female; Fever; Humans; Lymphoma; Male; Middle Aged; Neoplasms; Piperacillin; Prospective Studies	1991
[Amikacin in the treatment of genito-urinary an pulmonary infections in oncologic patients]. Minerva medica, 1991, Volume: 82, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Female; Genital Diseases, Female; Genital Diseases, Male; Humans; Male; Middle Aged; Neoplasms; Respiratory Tract Infections; Urinary Tract Infections	1991
Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer In The Journal of infectious diseases, 1991, Volume: 163, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; Gram-Positive Bacteria; Humans; Infant; Male; Middle Aged; Neoplasms; Prospective Studies; Sepsis; Vancomycin	1991
Gram-positive bacteraemia in granulocytopenic cancer patients. European journal of cancer (Oxford, England : 1990), 1990, Volume: 26, Issue:5 Topics: Agranulocytosis; Amikacin; Azlocillin; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Gram-Positive Bacteria; Humans; Neoplasms; Prospective Studies; Randomized Controlled Trials as Topic; Sepsis	1990
Ceftazidime plus teicoplanin versus ceftazidime plus amikacin as empiric therapy for fever in cancer patients with granulocytopenia. British journal of haematology, 1990, Volume: 76 Suppl 2 Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Fever; Glycopeptides; Humans; Leukemia; Male; Middle Aged; Neoplasms; Prospective Studies; Sepsis; Teicoplanin	1990
Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia. The New England journal of medicine, 1987, 12-31, Volume: 317, Issue:27 Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Azlocillin; Ceftazidime; Child; Child, Preschool; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Humans; Leukemia; Leukocyte Count; Male; Middle Aged; Neoplasms; Prognosis; Random Allocation; Regression Analysis; Sepsis	1987
Vancomycin, ticarcillin, and amikacin compared with ticarcillin-clavulanate and amikacin in the empirical treatment of febrile, neutropenic children with cancer. The New England journal of medicine, 1988, Oct-20, Volume: 319, Issue:16 Topics: Adolescent; Adult; Agranulocytosis; Amikacin; Bacterial Infections; Child; Child, Preschool; Clavulanic Acids; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Neoplasms; Neutropenia; Penicillins; Random Allocation; Ticarcillin; Vancomycin	1988
Amikacin plus ceftazidime versus amikacin plus piperacillin versus amikacin plus aztreonam in infections in neoplastic patients with granulocytopenia. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:6 Topics: Adult; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Aztreonam; Bacterial Infections; Ceftazidime; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Neoplasms; Piperacillin; Random Allocation	1987
[Cefmenoxime or piperacillin plus amikacin. A prospective randomized comparison of empiric antibiotic therapy of febrile granulocytopenic cancer patients]. Gan to kagaku ryoho. Cancer & chemotherapy, 1987, Volume: 14, Issue:3 Pt 1 Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Cefmenoxime; Cefotaxime; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Piperacillin; Prospective Studies; Random Allocation	1987
A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients. The American journal of medicine, 1986, May-30, Volume: 80, Issue:5C Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Blood Bactericidal Activity; Blood Coagulation Disorders; Clinical Trials as Topic; Drug Hypersensitivity; Drug Synergism; Drug Therapy, Combination; Fever; Hearing Disorders; Humans; Infections; Kanamycin; Kidney Diseases; Microbial Sensitivity Tests; Middle Aged; Moxalactam; Neoplasms; Piperacillin; Random Allocation	1986
Combination of amikacin and ceftazidime as empiric treatment of febrile leukopenic patients affected by solid tumors. International journal of clinical pharmacology, therapy, and toxicology, 1987, Volume: 25, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Amikacin; Bacterial Infections; Ceftazidime; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Humans; Immune Tolerance; Leukopenia; Middle Aged; Neoplasms	1987
Review of amikacin usage in the EORTC trials. The American journal of medicine, 1985, Jul-15, Volume: 79, Issue:1A Topics: Agranulocytosis; Amikacin; Anti-Bacterial Agents; Bacterial Infections; Clinical Trials as Topic; Drug Therapy, Combination; Fever; Gentamicins; Humans; International Cooperation; Kanamycin; Kidney Diseases; Lactams; Neoplasms; Neutropenia	1985

Other Studies

45 other study(ies) available for amikacin and Benign Neoplasms

Article	Year
Synthesis, antibacterial and cytotoxic activities of new biflorin-based hydrazones and oximes. Bioorganic & medicinal chemistry letters, 2016, Jan-15, Volume: 26, Issue:2 Topics: Anti-Bacterial Agents; Antineoplastic Agents, Phytogenic; Bacteria; Bacterial Infections; Cell Line, Tumor; Humans; Hydrazones; Microbial Sensitivity Tests; Naphthoquinones; Neoplasms; Oximes; Scrophulariaceae	2016
Failure to predict amikacin elimination in critically ill patients with cancer based on the estimated glomerular filtration rate: applying PBPK approach in a therapeutic drug monitoring study. European journal of clinical pharmacology, 2023, Volume: 79, Issue:7 Topics: Adult; Amikacin; Anti-Bacterial Agents; Critical Illness; Drug Monitoring; Glomerular Filtration Rate; Humans; Neoplasms	2023
Activity of Cefiderocol and Comparators against Isolates from Cancer Patients. Antimicrobial agents and chemotherapy, 2020, 04-21, Volume: 64, Issue:5 Topics: Acinetobacter; Amikacin; Anti-Bacterial Agents; Azabicyclo Compounds; Carbapenem-Resistant Enterobacteriaceae; Cefiderocol; Ceftazidime; Cephalosporins; Drug Combinations; Gram-Negative Bacteria; Humans; Meropenem; Microbial Sensitivity Tests; Neoplasms; Pseudomonas aeruginosa; Stenotrophomonas maltophilia	2020
Cefepime Versus Cefepime Plus Amikacin as an Initial Antibiotic Choice for Pediatric Cancer Patients With Febrile Neutropenia in an Era of Increasing Cefepime Resistance. The Pediatric infectious disease journal, 2020, Volume: 39, Issue:10 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Cefepime; Chemotherapy-Induced Febrile Neutropenia; Child; Child, Preschool; Drug Resistance, Bacterial; Drug Therapy, Combination; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Infant; Male; Neoplasms; Retrospective Studies; Treatment Outcome	2020
Covariates of amikacin disposition in a large pediatric oncology cohort. International journal of clinical pharmacology and therapeutics, 2021, Volume: 59, Issue:1 Topics: Amikacin; Anti-Bacterial Agents; Child; Drug Monitoring; Humans; Models, Statistical; Neoplasms; Randomized Controlled Trials as Topic; Retrospective Studies; Software	2021
Impact of Disease on Amikacin Pharmacokinetics and Dosing in Children. Therapeutic drug monitoring, 2019, Volume: 41, Issue:1 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Burns; Child; Child, Preschool; Female; Gram-Negative Bacterial Infections; Humans; Infant; Male; Neoplasms; Retrospective Studies	2019
Hearing loss and vestibular dysfunction among children with cancer after receiving aminoglycosides. Pediatric blood & cancer, 2013, Volume: 60, Issue:11 Topics: Amikacin; Aminoglycosides; Antineoplastic Agents; Child; Child, Preschool; Female; Hearing Loss; Humans; Male; Neoplasms; Vestibular Diseases; Vestibular Evoked Myogenic Potentials	2013
Invited reply to amikacin ototoxicity in children with cancer: the problem is the administration schedule. Pediatric blood & cancer, 2014, Volume: 61, Issue:2 Topics: Amikacin; Aminoglycosides; Antineoplastic Agents; Female; Hearing Loss; Humans; Male; Neoplasms; Vestibular Diseases	2014
Administration schedule and ototoxicity of amikacin in children with cancer. Pediatric blood & cancer, 2014, Volume: 61, Issue:2 Topics: Amikacin; Aminoglycosides; Antineoplastic Agents; Female; Hearing Loss; Humans; Male; Neoplasms; Vestibular Diseases	2014
High-risk febrile neutropenia and its management in children with solid tumors and lymphoma. Turkish journal of medical sciences, 2015, Volume: 45, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; C-Reactive Protein; Calcitonin; Calcitonin Gene-Related Peptide; Child; Febrile Neutropenia; Female; Humans; Imipenem; Lymphoma; Male; Neoplasms; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Protein Precursors	2015
Tinnitus onset rates from chemotherapeutic agents and ototoxic antibiotics: results of a large prospective study. Journal of the American Academy of Audiology, 2010, Volume: 21, Issue:6 Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Carboplatin; Cisplatin; Cross-Sectional Studies; Female; Gentamicins; Hearing Tests; Humans; Incidence; Male; Middle Aged; Neoplasms; Prospective Studies; Risk; Time Factors; Tinnitus; Tobramycin; Vancomycin; Veterans	2010
[Cefepime versus piperacillin/tazobactam with or without amikacin in the treatment of febrile hematological and oncological neutropenic patients in an internal medicine ward]. Harefuah, 2010, Volume: 149, Issue:12 Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Treatment Outcome	2010
Empirical therapy with ceftazidime combined with levofloxacin or once-daily amikacin for febrile neutropenia in patients with neoplasia: a prospective comparative study. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2012, Volume: 31, Issue:7 Topics: Aged; Amikacin; Anti-Bacterial Agents; Ceftazidime; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Kidney Diseases; Levofloxacin; Male; Middle Aged; Neoplasms; Neutropenia; Ofloxacin; Prospective Studies; Survival Analysis; Treatment Outcome	2012
[Cefepime-amikacin combination in febrile neutropenic children with malignant hemopathy or tumor]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2003, Volume: 10, Issue:4 Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Bacterial Infections; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Fever; Hematologic Neoplasms; Humans; Infant; Neoplasms; Neutropenia; Patient Selection; Prognosis; Retrospective Studies; Time Factors; Treatment Outcome	2003
Differences in the proportions of fluoroquinolone-resistant Gram-negative bacteria isolated from bacteraemic children with cancer in two Italian centres. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2005, Volume: 11, Issue:6 Topics: Amikacin; Anti-Bacterial Agents; Bacteremia; Ceftazidime; Child; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals, Pediatric; Humans; Imipenem; Italy; Neoplasms; Retrospective Studies	2005
Usefulness of antibiotic-lock technique in management of oncology patients with uncomplicated bacteremia related to tunneled catheters. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:4 Topics: Adolescent; Adult; Amikacin; Anti-Bacterial Agents; Bacteremia; Catheters, Indwelling; Female; Humans; Male; Middle Aged; Neoplasms; Prospective Studies; Vancomycin	2005
Are we finally ready for outpatient management of febrile neutropenia? Pediatric blood & cancer, 2007, Volume: 49, Issue:6 Topics: Ambulatory Care; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Costs and Cost Analysis; Female; Humans; Injections, Intravenous; Length of Stay; Male; Monitoring, Physiologic; Neoplasms; Neutropenia; Patient Discharge; Prospective Studies; Risk Factors; Safety Management; Sepsis; Time Factors	2007
Treatment of severe infections in patients with cancer. The role of new acyl-penicillins. Archives of internal medicine, 1982, Oct-25, Volume: 142, Issue:11 Topics: Amikacin; Azlocillin; Bacterial Infections; Drug Therapy, Combination; Humans; Mezlocillin; Neoplasms; Penicillins; Piperacillin	1982
[Sulbenicillin and amikacin for febrile patients with cancer--with special reference to granulocytopenia]. Gan to kagaku ryoho. Cancer & chemotherapy, 1983, Volume: 10, Issue:11 Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Male; Middle Aged; Neoplasms; Penicillin G; Sulbenicillin	1983
Can antibacterial therapy be discontinued in persistently febrile granulocytopenic cancer patients? The American journal of medicine, 1984, Volume: 76, Issue:3 Topics: Agranulocytosis; Amikacin; Amphotericin B; Anti-Bacterial Agents; Fever; Humans; Lactams; Neoplasms	1984
Long-term amikacin use. Effects on aminoglycoside susceptibility patterns of gram-negative bacilli. JAMA, 1982, Sep-10, Volume: 248, Issue:10 Topics: Amikacin; Aminoglycosides; Bacterial Infections; Drug Resistance, Microbial; Enterobacteriaceae; Gentamicins; Humans; Kanamycin; Neoplasms; Pseudomonas aeruginosa; Time Factors	1982
Renal and Auditory toxic effects of amikacin in children with cancer. American journal of diseases of children (1960), 1982, Volume: 136, Issue:3 Topics: Adolescent; Amikacin; Bacterial Infections; Child; Child, Preschool; Hearing Loss; Hearing Loss, High-Frequency; Humans; Infant; Kanamycin; Kidney Diseases; Neoplasms	1982
Efficacy of amikacin and ticarcillin as empiric therapy in febrile neutropenic children with cancer. Medical and pediatric oncology, 1981, Volume: 9, Issue:5 Topics: Adolescent; Agranulocytosis; Amikacin; Bacterial Infections; Child; Child, Preschool; Evaluation Studies as Topic; Female; Humans; Infant; Kanamycin; Male; Neoplasms; Neutropenia; Penicillins; Ticarcillin	1981
[Assessment of pharmacokinetic parameters of amikacin in a group of neutropenic patients in onco-hematology]. Pathologie-biologie, 1996, Volume: 44, Issue:4 Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Antineoplastic Combined Chemotherapy Protocols; Female; France; Hospital Units; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Neutropenia; Retrospective Studies	1996
Aetiology, cost of antimicrobial therapy and outcome in neutropenic patients who developed bacteraemia during antimicrobial prophylaxis: a case-control study. International journal of antimicrobial agents, 1998, Volume: 10, Issue:4 Topics: Amikacin; Amphotericin B; Antibiotic Prophylaxis; Bacteremia; Bacterial Infections; Case-Control Studies; Catheters, Indwelling; Ceftazidime; Drug Therapy, Combination; Enterococcus; Female; Fluconazole; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Humans; Male; Neoplasms; Neutropenia; Ofloxacin; Retrospective Studies; Streptococcal Infections; Treatment Outcome; Vancomycin; Xanthomonas	1998
Strategies for cost-containment: once-daily ceftriaxone plus amikacin as empiric therapy for febrile granulocytopenic children with cancer. Journal of chemotherapy (Florence, Italy), 1999, Volume: 11, Issue:1 Topics: Adolescent; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost Control; Drug Administration Schedule; Drug Therapy, Combination; Female; Fever of Unknown Origin; Humans; Infant; Male; Neoplasms; Retrospective Studies; Treatment Outcome	1999
Efficacy of cefepime and amikacin in the empiric treatment of febrile neutropenic children with cancer. Medical and pediatric oncology, 2000, Volume: 34, Issue:4 Topics: Adolescent; Amikacin; Anti-Bacterial Agents; Bacteremia; Cefepime; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Escherichia coli Infections; Female; Fever; Fever of Unknown Origin; Humans; Infant; Male; Neoplasms; Neutropenia; Staphylococcal Infections; Streptococcal Infections; Treatment Outcome	2000
In vitro antibacterial activity of four aminoglycosides and two semisynthetic penicillins on fresh clinical isolates from cancer patients. European journal of cancer, 1979, Volume: 15 Suppl Topics: Amikacin; Aminoglycosides; Bacterial Infections; Carbenicillin; Gentamicins; Humans; Microbial Sensitivity Tests; Neoplasms; Netilmicin; Penicillin Resistance; Penicillins; Ticarcillin; Tobramycin	1979
Amikacin and cephalothin: empiric regimen for granulocytopenic cancer patients. Antimicrobial agents and chemotherapy, 1977, Volume: 12, Issue:5 Topics: Adult; Agranulocytosis; Amikacin; Cephalothin; Drug Therapy, Combination; Escherichia coli Infections; Female; Humans; Kanamycin; Male; Neoplasms; Pseudomonas Infections	1977
Multiple-dose amikacin kinetics in pediatric oncology patients. Clinical pharmacology and therapeutics, 1979, Volume: 26, Issue:5 Topics: Adolescent; Amikacin; Child; Child, Preschool; Drug Administration Schedule; Humans; Infant; Kanamycin; Kinetics; Mathematics; Neoplasms	1979
Amikacin pharmacokinetics in pediatric patients with malignancy. Antimicrobial agents and chemotherapy, 1979, Volume: 16, Issue:6 Topics: Adolescent; Amikacin; Bacterial Infections; Blood Urea Nitrogen; Child; Child, Preschool; Creatinine; Female; Half-Life; Humans; Infant; Infusions, Parenteral; Kanamycin; Kinetics; Male; Neoplasms	1979
Hypocalcemia with hypoparathyroidism and renal tubular dysfunction associated with aminoglycoside therapy. Cancer, 1977, Volume: 39, Issue:4 Topics: Adult; Aged; Amikacin; Aminoglycosides; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Doxorubicin; Female; Gentamicins; Humans; Hypocalcemia; Hypoparathyroidism; Kidney Diseases; Kidney Tubules; Leukemia; Male; Middle Aged; Neoplasms; Parathyroid Hormone; Phosphates; Sisomicin; Syndrome; Tobramycin	1977
The pharmacokinetics of amikacin in children. The Journal of pediatrics, 1977, Volume: 91, Issue:2 Topics: Adolescent; Amikacin; Anemia, Aplastic; Appendicitis; Child; Child, Preschool; Cystic Fibrosis; Female; Half-Life; Humans; Kanamycin; Kidney; Leukemia; Male; Metabolic Clearance Rate; Neoplasms; Neutropenia; Pelvic Inflammatory Disease	1977
Carbenicillin, cefazolin, and amikacin as an empiric therapy for febrile granulocytopenic cancer patients. Cancer treatment reports, 1977, Volume: 61, Issue:8 Topics: Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Anti-Bacterial Agents; Carbenicillin; Cefazolin; Drug Therapy, Combination; Female; Fever; Humans; Infections; Male; Middle Aged; Neoplasms	1977
Amikacin for treatment of infections in patients with malignant diseases. The Journal of infectious diseases, 1976, Volume: 134 SUPPL Topics: Adolescent; Adult; Aged; Amikacin; Bacterial Infections; Blood Cell Count; Enterobacteriaceae Infections; Female; Humans; Kanamycin; Male; Middle Aged; Neoplasms; Neutrophils; Pseudomonas Infections	1976
Ceftazidime and amikacin as empiric treatment of febrile episodes in neutropenic patients in Saudi Arabia. The Journal of infection, 1992, Volume: 25, Issue:1 Topics: Adult; Amikacin; Ceftazidime; Fever; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitals, University; Humans; Mycoses; Neoplasms; Neutropenia; Saudi Arabia; Sepsis; Treatment Outcome	1992
Single daily dose ceftriaxone plus amikacin treatment of febrile episodes in neutropenic patients attending day hospital for hematologic malignancies. Oncology, 1992, Volume: 49, Issue:1 Topics: Adolescent; Adult; Aged; Amikacin; Antineoplastic Combined Chemotherapy Protocols; Ceftriaxone; Day Care, Medical; Drug Therapy, Combination; Female; Fever; Hematologic Diseases; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Opportunistic Infections; Pilot Projects	1992
Netilmicin plus ceftriaxone versus amikacin plus ceftriaxone in the treatment of infections in granulocytopenic patients. Chemotherapy, 1992, Volume: 38, Issue:1 Topics: Adult; Agranulocytosis; Amikacin; Bacterial Infections; Ceftriaxone; Drug Therapy, Combination; Female; Fever; Humans; Male; Middle Aged; Neoplasms; Netilmicin; Retrospective Studies	1992
Amikacin pharmacokinetics in patients receiving high-dose cancer chemotherapy. Antimicrobial agents and chemotherapy, 1991, Volume: 35, Issue:5 Topics: Adolescent; Adult; Aged; Amikacin; Analysis of Variance; Antineoplastic Agents; Body Weight; Female; Half-Life; Humans; Male; Middle Aged; Neoplasms; Neutropenia; Regression Analysis	1991
In vitro activity of trospectomycin (U-63366F), a novel spectinomycin analog, against gram-positive isolates from cancer patients. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:3 Topics: Amikacin; Anti-Bacterial Agents; Cephalothin; Gram-Positive Bacteria; Humans; Neoplasms; Spectinomycin; Staphylococcus; Streptococcus; Vancomycin	1989
[Combined antibacterial therapy of infectious complications in oncological patients]. Antibiotiki i khimioterapiia = Antibiotics and chemoterapy [sic], 1989, Volume: 34, Issue:9 Topics: Amikacin; Bacterial Infections; Carbenicillin; Cefazolin; Drug Therapy, Combination; Humans; Immune Tolerance; Neoplasms; Opportunistic Infections	1989
[Infections in neutropenic children with neoplasms. Case series contribution]. Minerva pediatrica, 1988, Volume: 40, Issue:6 Topics: Adolescent; Adult; Agranulocytosis; Amikacin; Bacterial Infections; Ceftazidime; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Infant; Leukemia; Lymphoma; Male; Neoplasms; Neutropenia	1988
Treatment of gram-negative bacteremia in patients with cancer and granulocytopenia. The New England journal of medicine, 1988, Jun-23, Volume: 318, Issue:25 Topics: Agranulocytosis; Amikacin; Ceftazidime; Drug Therapy, Combination; Gram-Negative Bacteria; Humans; Neoplasms; Sepsis	1988
Empirical antimicrobial therapy with Timentin plus amikacin in febrile granulocytopenic cancer patients. The Journal of antimicrobial chemotherapy, 1986, Volume: 17 Suppl C Topics: Adult; Aged; Agranulocytosis; Amikacin; Bacteria; Bacterial Infections; Clavulanic Acids; Drug Combinations; Drug Evaluation; Drug Therapy, Combination; Female; Fever; Humans; Kanamycin; Male; Middle Aged; Neoplasms; Penicillin Resistance; Penicillins; Sepsis; Ticarcillin	1986
[Empiric therapy with piperacillin plus amikacin for febrile patients with cancer--with emphasis on granulocytopenia]. Gan to kagaku ryoho. Cancer & chemotherapy, 1985, Volume: 12, Issue:6 Topics: Acute Disease; Adolescent; Adult; Aged; Agranulocytosis; Amikacin; Bacterial Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Kanamycin; Leukemia; Leukocyte Count; Lymphoma; Male; Middle Aged; Neoplasms; Piperacillin	1985